Department of Ophthalmology, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France.
Research Support Unit, Mercy Hospital, Metz-Thionville Regional Hospital Center, Metz, France.
PLoS One. 2022 Apr 29;17(4):e0263686. doi: 10.1371/journal.pone.0263686. eCollection 2022.
This retrospective cohort study assessed the evolution of corneal transplantation and its indications in the last 21 years (2000-2020) in a specialized ophthalmology department in a tertiary referral center in France.
The surgical techniques and indications, patient age and sex, and postoperative best-corrected visual acuity (BCVA) 6 months after keratoplasty were extracted.
In total, 1042 eyes underwent keratoplasty in 2000-2020. Annual numbers of corneal transplantations increased by 2.2-fold. Penetrating keratoplasty (PKP) was the sole technique for the first 11 years. Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK) were introduced in 2011 and 2014, respectively. Cases of both quickly increased, accounting for 28% and 41% of cases in 2015-2020, respectively. Eventually, DSAEK and DMEK were respectively used for most pseudophakic bullous keratopathy (PBK) and all Fuchs endothelial cell dystrophy (FECD) cases. PKP cases declined to 27%. Deep anterior lamellar keratoplasty (DALK) was rare (3% of all cases). These changes associated with rises in PBK and particularly FECD cases, and a strong decline in keratoconus, causing FECD, PBK, and keratoconus to move from being the 4th, 1st, and 3rd most common indications to the 1st, 2nd, and 6th, respectively. On average, BCVA improved by 0.1-0.3 logMAR. Patient age dropped steadily over time. Female predominance was observed.
The invention of DSAEK and then DMEK precipitated an enormous change in clinical practice and a large expansion of keratoplasty to new indications. This study confirms and extends previous findings in other countries.
本回顾性队列研究评估了 21 年来(2000-2020 年)在法国一家三级转诊中心的专门眼科部门中角膜移植及其适应证的演变。
提取手术技术和适应证、患者年龄和性别,以及穿透性角膜移植(PKP)术后 6 个月的最佳矫正视力(BCVA)。
2000-2020 年共进行了 1042 例眼的角膜移植。角膜移植的年数量增加了 2.2 倍。前 11 年仅采用穿透性角膜移植术(PKP)。2011 年和 2014 年分别引入了撕囊自动化内皮角膜移植术(DSAEK)和内皮层角膜内皮移植术(DMEK)。这两种手术的病例数都迅速增加,分别占 2015-2020 年病例的 28%和 41%。最终,DSAEK 和 DMEK 分别用于大多数白内障后泡性角膜病变(PBK)和所有 Fuchs 内皮细胞营养不良(FECD)病例。PKP 病例减少到 27%。深层前板层角膜移植术(DALK)很少见(占所有病例的 3%)。这些变化与 PBK 和特别是 FECD 病例的增加以及导致 FECD、PBK 和圆锥角膜的病例数量减少有关,使 FECD、PBK 和圆锥角膜的病例数分别从第 4、1 和第 3 位最常见的适应证变为第 1、2 和第 6 位最常见的适应证。平均而言,BCVA 提高了 0.1-0.3 logMAR。患者年龄随时间稳步下降。观察到女性占主导地位。
DSAEK 的发明,然后是 DMEK 的发明,促成了临床实践的巨大变化,并使角膜移植扩展到新的适应证。本研究证实并扩展了其他国家的先前发现。